Financial statements Rd Badania Kliniczne
Cash inflows of RD BADANIA KLINICZNE
Year
|
2018
|
2022
|
2023
|
2024
|
---|---|---|---|---|
Net cash from operating expenses | 30 716,36 | - | - | - |
Net cash flow from investing activities | -16 673,68 | - | - | - |
Net cash flow from financial activities | -80,95 | - | - | - |
Total net cash flow | 13 961,73 | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.